Skip Nav Destination
A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies
High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy
End-stage liver disease in persons with hemophilia and transfusion-associated infections
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia
Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)
Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients
Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature
Distinct contributions of CD4+ and CD8+naive and memory T-cell subsets to overall T-cell–receptor repertoire complexity following transplantation of T-cell–depleted CD34-selected hematopoietic progenitor cells from unrelated donors
Issue Archive
September 1 2002
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies
Clinical Trials & Observations
Stephen Couban,David R. Simpson,Michael J. Barnett,Christopher Bredeson,Lothar Hubesch,Kang Howson-Jan,Tsiporah B. Shore,Irwin R. Walker,Peter Browett,Hans A. Messner,Tony Panzarella,Jeffrey H. Lipton,for the Canadian Bone Marrow Transplant Group
ERRATA
REVIEW ARTICLES
CHEMOKINES
Efficacious immunomodulatory activity of the chemokine stromal cell–derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell–dependent antitumor responses
Kyriaki Dunussi-Joannopoulos,Krystyna Zuberek,Kathlene Runyon,Robert G. Hawley,Anthony Wong,Jamie Erickson,Steve Herrmann,John P. Leonard
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
Clinical Trials & Observations
Marco Ladetto,Paolo Corradini,Sonia Vallet,Fabio Benedetti,Umberto Vitolo,Maurizio Martelli,Maura Brugiatelli,Paolo Coser,Alessio Perrotti,Ignazio Majolino,Giuseppe Fioritoni,Sergio Morandi,Maurizio Musso,Renato Zambello,Teodoro Chisesi,Nicola Di Renzo,Paolo Vivaldi,Alberto De Crescenzo,Andrea Gallamini,Flavia Salvi,Gino Santini,Carola Boccomini,Marco Sorio,Monica Astolfi,Daniela Drandi,Alessandro Pileri,Corrado Tarella
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome
Clinical Trials & Observations
Yogen Saunthararajah,Ryotaro Nakamura,Jun-Mo Nam,Jamie Robyn,Fausto Loberiza,Jaroslaw P. Maciejewski,Toni Simonis,Jeffrey Molldrem,Neal S. Young,A. John Barrett
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy
Clinical Trials & Observations
Mauro Malnati,Francesco Broccolo,Silvia Nozza,Loredana Sarmati,Silvia Ghezzi,Giuseppe Locatelli,Fanny Delfanti,Brunella Capiluppi,Anna Careddu,Massimo Andreoni,Paolo Monini,Guido Poli,Adriano Lazzarin,Paolo Lusso,Giuseppe Tambussi
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy
Clinical Trials & Observations
Philippe Moreau,Thierry Facon,Xavier Leleu,Nadine Morineau,Pauline Huyghe,Jean-Luc Harousseau,Régis Bataille,Hervé Avet-Loiseau,for the Intergroupe Francophone du Myélome
End-stage liver disease in persons with hemophilia and transfusion-associated infections
Clinical Trials & Observations
James J. Goedert,M. Elaine Eyster,Michael M. Lederman,Titica Mandalaki,Philippe de Moerloose,Gilbert C. White, II,Anne L. Angiolillo,Naomi L. C. Luban,Kenneth E. Sherman,Marilyn Manco-Johnson,Liliana Preiss,Cindy Leissinger,Craig M. Kessler,Alan R. Cohen,Donna DiMichele,Margaret W. Hilgartner,Louis M. Aledort,Barbara L. Kroner,Philip S. Rosenberg,Angelos Hatzakis,for the Multicenter Hemophilia Cohort Study
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia
Clinical Trials & Observations
Hagop M. Kantarjian,Susan O'Brien,Jorge E. Cortes,Sergio A. Giralt,Mary Beth Rios,Jianqin Shan,Francis J. Giles,Deborah A. Thomas,Stefan Faderl,Marcos De Lima,Guillermo Garcia-Manero,Richard Champlin,Ralph Arlinghaus,Moshe Talpaz
Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia
Clinical Trials & Observations
Lee-Yung Shih,Tung-Liang Lin,Chang-Liang Lai,Po Dunn,Jin-Hou Wu,Po-Nan Wang,Ming-Chung Kuo,Lai-Chu Lee
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes
Clinical Trials & Observations
Peter A. McSweeney,Richard A. Nash,Keith M. Sullivan,Jan Storek,Leslie J. Crofford,Roger Dansey,Maureen D. Mayes,Kevin T. McDonagh,J. Lee Nelson,Theodore A. Gooley,Leona A. Holmberg,C. S. Chen,Mark H. Wener,Katherine Ryan,Julie Sunderhaus,Ken Russell,John Rambharose,Rainer Storb,Daniel E. Furst
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
Clinical Trials & Observations
John E. Wagner,Juliet N. Barker,Todd E. DeFor,K. Scott Baker,Bruce R. Blazar,Cindy Eide,Anne Goldman,John Kersey,William Krivit,Margaret L. MacMillan,Paul J. Orchard,Charles Peters,Daniel J. Weisdorf,Norma K. C. Ramsay,Stella M. Davies
Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery
Clinical Trials & Observations
Suparno Chakrabarti,Vivien Mautner,Husam Osman,Kathryn E. Collingham,Chris D. Fegan,Paul E. Klapper,Paul A. H. Moss,Donald W. Milligan
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)
Clinical Trials & Observations
Joseph A. Sparano,Edie Weller,Tipu Nazeer,Thomas Habermann,Ann E. Traynor,Jane Manalo,Peter Cassileth
Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients
Clinical Trials & Observations
Jose I. Chacón,Manuela Mollejo,Enriqueta Muñoz,Patricia Algara,Marisol Mateo,Luis Lopez,Jesús Andrade,Iciar Garcı́a Carbonero,Beatriz Martı́nez,Miguel A. Piris,Miguel A. Cruz
GENE THERAPY
Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors
Clemens-Martin Wendtner,David M. Kofler,Hans D. Theiss,Christian Kurzeder,Raymund Buhmann,Carmen Schweighofer,Luca Perabo,Susanne Danhauser-Riedl,Jens Baumert,Wolfgang Hiddemann,Michael Hallek,Hildegard Büning
Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques
Amit C. Nathwani,Andrew M. Davidoff,Hideki Hanawa,Yunyu Hu,Fredric A. Hoffer,Alexander Nikanorov,Clive Slaughter,Catherine Y. C. Ng,Junfang Zhou,Jay N. Lozier,Timothy D. Mandrell,Elio F. Vanin,Arthur W. Nienhuis
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
B cells immortalized by a mini–Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells
Andreas Moosmann,Naeem Khan,Mark Cobbold,Caroline Zentz,Henri-Jacques Delecluse,Gabi Hollweck,Andrew D. Hislop,Neil W. Blake,Debbie Croom-Carter,Barbara Wollenberg,Paul A. H. Moss,Reinhard Zeidler,Alan B. Rickinson,Wolfgang Hammerschmidt
Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis
Athanasia Mouzaki,Maria Theodoropoulou,Ioannis Gianakopoulos,Vassiliki Vlaha,Maria-Christina Kyrtsonis,Alice Maniatis
NEOPLASIA
A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)
Urban Novak,Elisabeth Oppliger Leibundgut,Jörg Hager,Dominique Mühlematter,Martine Jotterand,Celine Besse,Nicolas Leupin,Daniel Ratschiller,Jeanette Papp,Gina Kearsey,Stefan Aebi,Hans Graber,Rolf Jaggi,Jean-Marc Lüthi,Sandrine Meyer-Monard,Mark Lathrop,Andreas Tobler,Martin F. Fey
Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature
Clinical Trials & Observations
Annette Lebeau,Evelyn Zeindl-Eberhart,Eva-Christina Müller,Josef Müller-Höcker,Peter Roman Jungblut,Bertold Emmerich,Udo Löhrs
PHAGOCYTES
Essential role of the C5a receptor in E coli–induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation
Tom Eirik Mollnes,Ole-Lars Brekke,Michael Fung,Hilde Fure,Dorte Christiansen,Grethe Bergseth,Vibeke Videm,Knut Tore Lappegård,Jörg Köhl,John D. Lambris
RED CELLS
Absence of CD47 in protein 4.2–deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex: Presented at the 43rd Annual Meeting of the American Society of Hematology, Orlando, FL, December 7-11, 2001, and abstract published in Blood. 2001;98:(suppl1):10a.
Lesley J. Bruce,Sandip Ghosh,May Jean King,D. Mark Layton,William J. Mawby,Gordon W. Stewart,Per-Arne Oldenborg,Jean Delaunay,Michael J. A. Tanner
TRANSPLANTATION
BRIEF REPORTS
Distinct contributions of CD4+ and CD8+naive and memory T-cell subsets to overall T-cell–receptor repertoire complexity following transplantation of T-cell–depleted CD34-selected hematopoietic progenitor cells from unrelated donors
Brief Report
Matthias Eyrich,Tanja Croner,Christine Leiler,Peter Lang,Peter Bader,Thomas Klingebiel,Dietrich Niethammer,Paul G. Schlegel
CORRESPONDENCE
-
Cover Image
Cover Image
![issue cover]()
Advertisement
Email alerts
Advertisement
